Your session is about to expire
← Back to Search
Amnioinfusion for Birth-Related Brain Injury
Study Summary
This trial will test the feasibility and preliminary effects of room temperature amnioinfusion on tissue injury including HIE, a serious brain injury in infants that can cause long-term neurologic deficits.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have conditions like placental previa, HIV, or Hepatitis C that prevent certain pregnancy monitoring procedures.I am over 18 years old.I am unable to give consent by myself.
- Group 1: Standard of care (control arm)
- Group 2: Amnioinfusion at room temperature (intervention arm)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the upper limit of patients taking part in this medical experiment?
"Affirmative. According to data hosted on clinicaltrials.gov, this medical experiment was initially posted in June 15th 2022 and recently refreshed at the end of August 22nd 2022. 26 participants will be enrolled from a single location."
Is this research endeavor currently enrolling participants?
"Affirmative. According to information published on clinicaltrials.gov, this medical experiment was initially posted in June 15th 2022 and recently updated on August 23rd of the same year. The study is currently searching for 26 participants from one specified location."
Share this study with friends
Copy Link
Messenger